GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sectra AB (FRA:61L0) » Definitions » Research & Development

Sectra AB (FRA:61L0) Research & Development : €0.0 Mil (TTM As of Jul. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Sectra AB Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Sectra AB's Research & Development for the three months ended in Jul. 2024 was €0.0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Jul. 2024 was €0.0 Mil.

Sectra AB Research & Development Historical Data

The historical data trend for Sectra AB's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sectra AB Research & Development Chart

Sectra AB Annual Data
Trend Apr15 Apr16 Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23 Apr24
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Sectra AB Quarterly Data
Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Sectra AB Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Jul. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sectra AB  (FRA:61L0) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Sectra AB Research & Development Related Terms

Thank you for viewing the detailed overview of Sectra AB's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Sectra AB Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sectra AB (FRA:61L0) » Definitions » Research & Development
Comparable Companies
OSTO:GETI B OSTO:VITR OSTO:EKTA B OSTO:XVIVO OSTO:MCAP OSTO:CEVI OSTO:BICO OSTO:SEDANA OSTO:BACTI B OSTO:CRAD B ABT SYK BSX MDT XTER:SHL SZSE:300760 EW XAMS:PHIA DXCM STE
Traded in Other Exchanges
SECT B:Sweden SECTBs:UK 0A0L:UK
Address
Teknikringen 20, Linkoping, SWE, SE-583 30
Website
https://www.sectra.com
Sectra AB develops IT solutions and services for storing, viewing, and working with medical images. The operating business segments are Imaging IT Solutions, Secure Communications, Business Innovation, and Other Operations. It generates maximum revenue from the Imaging IT Solutions segment. The company also offers maintenance in the form of support, system monitoring, and consulting services related to integration, system design, data migration, and business development. Geographically, it derives a majority of its revenue from Sweden and also has a presence in the Netherlands; North America; Australia/New Zealand; the United Kingdom, and the Rest of Europe.

Sectra AB Headlines

No Headlines